MinorTrial status: Active, Not Recruiting to Completed
Primary completion date changed from estimate of Dec 2030 to Oct 30, 2015
Study completion date changed from estimate of Dec 2030 to Jun 8, 2026
Start date: Jul 2004 to Aug 25, 2004
v31
3 versionsRe-verified since Aug 28, 2023, no change to tracked fieldsv28-v30
NotablePrimary and study completion dates: Dec 2024 to Dec 2030v27
Study Status, Referencesv26
NotablePrimary and study completion dates: Dec 2021 to Dec 2024v25
Show 23 earlier versionsHide 23 earlier versions
NotablePrimary and study completion dates pushed to Dec 2021v24
Re-verified, no change to tracked fieldsv23
NotablePrimary completion date: Apr 2018 to Dec 2018v22
NotablePrimary completion date: Apr 2017 to Apr 2018v21
MinorStudy completion date: Dec 2017 to Dec 2020v20
MinorTrial status: Recruiting to Active, Not Recruiting
Site details revised
v19
NotablePrimary completion date: Apr 2015 to Apr 2017
Study completion date: Dec 2015 to Dec 2017
v18
NotablePrimary completion date: Apr 2014 to Apr 2015
Study completion date: Dec 2014 to Dec 2015
v17
Re-verified, no change to tracked fieldsv16
MinorPrimary completion date: Apr 2014v15
MinorStudy completion date: Dec 2011 to Dec 2014
Interventions: blood/saliva samples will be collected for protein/molecular analysis (Other) to Blood/saliva samples for protein/molecular analysis (Other)
Site contact updated
v14
MinorEligibility criteria expanded, about 1 wordv13
MinorStudy completion date: Dec 2009 to Dec 2011v12
Study Identification, Study Statusv11
MinorStudy completion date: Jul 2009 to Dec 2009v10
Re-verified, no change to tracked fieldsv9
MinorEnrollment target: 180 to 260v8Show 4 more changesShow less
Interventions: blood samples will be collected for protein analysis (Other) to blood/saliva samples will be collected for protein/molecular analysis (Other)
Eligibility criteria expanded, about 115 words
Site contact updated
Study arms: 2 to 4
MinorStudy completion date: Jul 2009
Interventions: blood samples will be collected for protein analysis (Procedure) to blood samples will be collected for protein analysis (Other)
Study arms: 0 to 2
v7
MinorCollaborators revised (2)v6
MinorCollaborators: 1 to 2
Eligibility criteria shortened, about 4 words
Study description expanded, about 4 words
v5
MinorInterventions: serum samples will be collected for protein analysis (Procedure) to blood samples will be collected for protein analysis (Procedure)
Study description revised
v4
MinorCollaborators: 2 to 1v3
MinorEligibility criteria shortened, about 10 wordsv2
Study First Submitted
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The specific aim of this research is to determine if the blood from brain-injured patients contains reproducible protein markers that appear prior to elevations in intracranial pressure (ICP).
Trial Details
NCT Number
NCT00178659
Lead Sponsor
The University of Texas Health Science Center, Houston Collaborators: TIRR/Mission Connect, The Center for Clinical and Translational Sciences (CCTS) Clinical Research Unit at The University of Texas Health Science Center at Houston